| Central Venous Catheters and Hemodialysis | Lifetime | 15 | ES 1 | 99.71 |
| Streptococcal Infections and Treatments | Lifetime | 16 | ES 1 | 99.72 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 20 | ES 1 | 99.79 |
| Nosocomial Infections in ICU | Lifetime | 12 | ES 2 | 99.77 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 40 | ES 2 | 99.79 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 27 | ES 1 | 99.60 |
| Mycobacterium research and diagnosis | Lifetime | 53 | ES 1 | 99.48 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 46 | ES 1 | 99.67 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 43 | ES 2 | 99.57 |
| Antifungal resistance and susceptibility | Lifetime | 48 | ES 2 | 99.69 |
| Antibiotic Use and Resistance | Lifetime | 48 | ES 4 | 99.56 |
| Pneumonia and Respiratory Infections | Lifetime | 109 | ES 5 | 99.49 |
| Infectious Diseases and Tuberculosis | Lifetime | 67 | ES 1 | 99.22 |
| Fungal Infections and Studies | Lifetime | 68 | ES 5 | 99.49 |
| Antibiotic Resistance in Bacteria | Lifetime | 179 | ES 13 | 99.33 |
| Infectious Diseases and Mycology | Lifetime | 52 | ES 3 | 99.01 |
| Tuberculosis Research and Epidemiology | Lifetime | 211 | ES 4 | 99.12 |
| Microscopic Colitis | Lifetime | 120 | ES 3 | 99.16 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 186 | ES 12 | 98.93 |
| Diagnosis and treatment of tuberculosis | Lifetime | 227 | ES 9 | 97.09 |
| Viral gastroenteritis research and epidemiology | Lifetime | 934 | ES 22 | 97.70 |
| Urinary Tract Infections Management | Lifetime | 415 | ES 6 | 97.32 |
| Hematological disorders and diagnostics | Lifetime | 310 | ES 7 | 95.65 |
| Orthopedic Infections and Treatments | Lifetime | 736 | ES 8 | 96.72 |
| Sepsis Diagnosis and Treatment | Lifetime | 878 | ES 14 | 96.61 |
| Bacterial biofilms and quorum sensing | Lifetime | 742 | ES 26 | 96.18 |
| Surgical site infection prevention | Lifetime | 385 | ES 9 | 94.19 |
| Medical and Biological Ozone Research | Lifetime | 225 | ES 5 | 91.79 |
| Neutropenia and Cancer Infections | Lifetime | 805 | ES 22 | 93.95 |
| Bacterial Infections and Vaccines | Lifetime | 977 | ES 24 | 93.98 |
| Actinomycetales infections and treatment | Lifetime | 159 | ES 5 | 91.77 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 355 | ES 17 | 92.01 |
| Infections and bacterial resistance | Lifetime | 233 | ES 11 | 91.74 |
| Otolaryngology and Infectious Diseases | Lifetime | 669 | ES 11 | 81.33 |
| Diphtheria, Corynebacterium, and Tetanus | Lifetime | 928 | ES 17 | 77.03 |
| Streptococcal Infections and Treatments | 2021-2025 | 4 | ES 1 | 99.03 |
| Antimicrobial Resistance in Staphylococcus | 2021-2025 | 11 | ES 2 | 98.97 |
| Nosocomial Infections in ICU | 2021-2025 | 16 | ES 3 | 98.50 |
| Clostridium difficile and Clostridium perfringens research | 2021-2025 | 57 | ES 1 | 96.42 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 148 | ES 8 | 98.03 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 108 | ES 6 | 95.97 |
| Microscopic Colitis | 2021-2025 | 339 | ES 14 | 94.52 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 635 | ES 44 | 85.62 |
| Otolaryngology and Infectious Diseases | 2021-2025 | 513 | ES 10 | 39.60 |
